| Product Code: ETC11389138 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Japan continued to import anticoagulants primarily from Germany, Switzerland, USA, Italy, and Metropolitan France. The market remained competitive with low concentration, as indicated by the Herfindahl-Hirschman Index (HHI). However, the industry experienced a decline with a compound annual growth rate (CAGR) of -5.32% from 2020 to 2024. Furthermore, the growth rate in 2024 saw a slight improvement but remained negative at -3.46%. These trends suggest a challenging market environment for anticoagulant import shipments into Japan, highlighting the need for strategic planning and adaptation by industry players.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Anticoagulants Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Anticoagulants Market - Industry Life Cycle |
3.4 Japan Anticoagulants Market - Porter's Five Forces |
3.5 Japan Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Japan Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Japan Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Japan |
4.2.2 Growing aging population leading to higher demand for anticoagulants |
4.2.3 Advancements in healthcare infrastructure and technology promoting better diagnosis and treatment |
4.3 Market Restraints |
4.3.1 Stringent government regulations and approval processes for new anticoagulant drugs |
4.3.2 High costs associated with anticoagulant medications leading to affordability issues |
4.3.3 Adverse side effects and risks associated with prolonged use of anticoagulants |
5 Japan Anticoagulants Market Trends |
6 Japan Anticoagulants Market, By Types |
6.1 Japan Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Japan Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 Japan Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 Japan Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 Japan Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Japan Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Japan Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Japan Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Japan Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 Japan Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 Japan Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 Japan Anticoagulants Market Import-Export Trade Statistics |
7.1 Japan Anticoagulants Market Export to Major Countries |
7.2 Japan Anticoagulants Market Imports from Major Countries |
8 Japan Anticoagulants Market Key Performance Indicators |
8.1 Patient adherence rate to anticoagulant therapy |
8.2 Number of hospitals and clinics offering anticoagulant treatment |
8.3 Rate of adoption of novel anticoagulant therapies |
8.4 Average age of patients prescribed anticoagulants |
8.5 Number of research studies and clinical trials related to anticoagulant treatments |
9 Japan Anticoagulants Market - Opportunity Assessment |
9.1 Japan Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Japan Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Japan Anticoagulants Market - Competitive Landscape |
10.1 Japan Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 Japan Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here